Discovery of 2-phenylethyl chromones as potent and selective CYP1B1 inhibitors
Wenming Chen, Wenchong Ye, Yinghong Long, Ye Zhang, Wen Zhou, Wei Wang
TL;DR
Researchers discovered a new class of compounds that effectively and selectively inhibit CYP1B1, a protein linked to cancer drug resistance.
Contribution
A novel scaffold of 2-phenylethyl chromones was identified as potent and selective CYP1B1 inhibitors.
Findings
Three compounds (CX-6, CX-9, CX-22) showed nanomolar anti-CYP1B1 activity with high selectivity.
CX-9 reversed docetaxel resistance in CYP1B1-overexpressing cells at 50 μM, comparable to 20 μM of α-naphthoflavone.
Molecular docking showed CX-9 and α-naphthoflavone bind similarly in CYP1B1’s active site.
Abstract
Cytochrome P4501B1 (CYP1B1), overexpressed in solid tumours but minimally in healthy tissues, is a promising anticancer target linked to chemoresistance. While CYP1B1 inhibitors can restore drug efficacy, most suffer from limited scaffold diversity and poor selectivity against other CYPs. We identified 2-(2-phenylethyl) chromones as a novel scaffold for anti-CYP1B1 activity and synthesised 24 derivatives with varied ring A/B substituents and established the SAR. Three compounds (CX-6, CX-9, CX-22) showed nanomolar anti-CYP1B1 activity and exceptional selectivity (SI > 230). In CYP1B1-overexpressing cells, the water-soluble and non-cytotoxic CX-9 (solubility > 100 μM) dose-dependently reversed docetaxel resistance, achieving efficacy at 50 μM comparable to 20 μM of the CYP1B1 inhibitor α-naphthoflavone (ANF). Molecular docking revealed similar binding modes for CX-9 and ANF in CYP1B1’s…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmacogenetics and Drug Metabolism · Eicosanoids and Hypertension Pharmacology · Protein Kinase Regulation and GTPase Signaling